Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
Clinical trial NCT02921022 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02921022
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2026-10-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.